TRURAPI

Google image searchProduct monograph

Active ingredient

insulin aspart, 100 UNIT/ML

DIN: 02529254

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS

Description: VIAL

Schedule: Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 03-NOV-2022

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10A — INSULINS AND ANALOGUES (ATC, ATC/DDD)
• A10AB — Insulins and analogues for injection, fast-acting (ATC, ATC/DDD)
• A10AB05 — INSULIN ASPART (ATC/DDD)

Reference brand drug: Novorapid, Fiasp, Kirsty, Trurapi

Pharmaceutical standard: MFR

External Links for Trurapi

Search on Google

• Trurapi side effects
• Trurapi dosage
• insulin aspart side effects
• insulin aspart dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find trurapi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.